Sandbox 124
From Proteopedia
m (Removing all content from page) |
|||
Line 1: | Line 1: | ||
- | + | Transpeptidases (TP), also known as penicillin-binding proteins (PBP), | |
+ | catalyze the cross-linking of peptidoglycan polymers during bacterial cell wall | ||
+ | synthesis. The natural transpeptidase substrate is the D-Ala-D-Ala | ||
+ | peptidoglycan side chain terminus. Beta-lactam (β-lactam) antibiotics, which | ||
+ | include penicillins, cephalosporins and carbapenems, bind and irreversibly | ||
+ | inhibit transpeptidases by mimicking the D-Ala-D-Ala substrate, resulting in | ||
+ | the inhibition of cell wall synthesis and ultimately bacterial cell growth. | ||
+ | Overuse and misuse of β-lactams has led to the generation of methicillinresistant | ||
+ | Staphylococcus aureus (MRSA) isolates that have acquired an | ||
+ | alternative transpeptidase, PBP2a, which is neither bound nor inhibited by β- | ||
+ | lactams. MRSA isolates are resistant to all β-lactams, can be hospital- or | ||
+ | community-acquired, and are often the cause of significant morbidity and | ||
+ | mortality. Furthermore, they are often only susceptible to “last resort | ||
+ | antibiotics”, such as vancomycin. Recently, two cephalosporins - ceftobiprole | ||
+ | and ceftaroline - that bind and inhibit PBP2a have been developed. The | ||
+ | Hostos-Lincoln Academy Students Modeling A Research Topic (SMART) | ||
+ | Team generated a model of the PBP2a/ceftobiprole complex (PDB 4DKI) | ||
+ | using 3D printing technology to illustrate the mechanism of action of | ||
+ | ceftobiprole. Supported by a grant from the Camille and Henry Dreyfus Foundation. |
Revision as of 18:42, 9 July 2013
Transpeptidases (TP), also known as penicillin-binding proteins (PBP), catalyze the cross-linking of peptidoglycan polymers during bacterial cell wall synthesis. The natural transpeptidase substrate is the D-Ala-D-Ala peptidoglycan side chain terminus. Beta-lactam (β-lactam) antibiotics, which include penicillins, cephalosporins and carbapenems, bind and irreversibly inhibit transpeptidases by mimicking the D-Ala-D-Ala substrate, resulting in the inhibition of cell wall synthesis and ultimately bacterial cell growth. Overuse and misuse of β-lactams has led to the generation of methicillinresistant Staphylococcus aureus (MRSA) isolates that have acquired an alternative transpeptidase, PBP2a, which is neither bound nor inhibited by β- lactams. MRSA isolates are resistant to all β-lactams, can be hospital- or community-acquired, and are often the cause of significant morbidity and mortality. Furthermore, they are often only susceptible to “last resort antibiotics”, such as vancomycin. Recently, two cephalosporins - ceftobiprole and ceftaroline - that bind and inhibit PBP2a have been developed. The Hostos-Lincoln Academy Students Modeling A Research Topic (SMART) Team generated a model of the PBP2a/ceftobiprole complex (PDB 4DKI) using 3D printing technology to illustrate the mechanism of action of ceftobiprole. Supported by a grant from the Camille and Henry Dreyfus Foundation.